US Patent 11124567 Anti-TREM2 antibodies and methods of use thereof
Patent 11124567 was granted and assigned to Denali Therapeutics on September, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
January 15, 2021
Date of Patent
September 21, 2021
Patent Applicant
Patent Application Number
20210115
Patent Citations Received
Patent Jurisdiction
Patent Number
Find more entities like US Patent 11124567 Anti-TREM2 antibodies and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
